Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy manufacturing
Manufacturing
Novartis unveils $23B investment to beef up US manufacturing, R&D
After similar reshoring pledges by Eli Lilly and J&J, Novartis is stepping up to the plate with a major investment in its U.S. operations.
Fraiser Kansteiner
Apr 10, 2025 3:18pm
Lyell telegraphs job cuts, facility closure for new unit ImmPact
Apr 7, 2025 3:23pm
AmplifyBio shutters amid tough cell and gene therapy market
Apr 7, 2025 10:38am
Artis BioSolutions launches with acquisition of Landmark Bio
Apr 2, 2025 10:22am
Cellares' cell therapy production tech wins key FDA designation
Apr 2, 2025 9:40am
J&J, Legend to invest $150M in Belgium cell therapy facility
Mar 12, 2025 2:15pm
